Your browser doesn't support javascript.
loading
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma.
Jones, Robin L; Mo, Gary; Baldwin, John R; Peterson, Patrick M; Ilaria, Robert L; Conti, Ilaria; Cronier, Damien M; Tap, William D.
Afiliación
  • Jones RL; University of Washington and Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. robin.Jones@rmh.nhs.uk.
  • Mo G; Royal Marsden Hospital and Institute of Cancer Research, London, UK. robin.Jones@rmh.nhs.uk.
  • Baldwin JR; Eli Lilly and Company, Lilly Corporate Center, 46285, Indianapolis, IN, USA.
  • Peterson PM; Eli Lilly and Company, Lilly Corporate Center, 46285, Indianapolis, IN, USA.
  • Ilaria RL; Eli Lilly and Company, Lilly Corporate Center, 46285, Indianapolis, IN, USA.
  • Conti I; Eli Lilly and Company, Lilly Corporate Center, 46285, Indianapolis, IN, USA.
  • Cronier DM; Celgene, Summit, NJ, USA.
  • Tap WD; Eli Lilly and Company, Lilly Corporate Center, 46285, Indianapolis, IN, USA.
Cancer Chemother Pharmacol ; 83(1): 191-199, 2019 01.
Article en En | MEDLINE | ID: mdl-30406840
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos